Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Lexaria Bioscience Corp.

LEXXW•NASDAQ
Healthcare
Biotechnology
$0.001
$-0.00(-77.36%)
U.S. Market opens in 1h 30m

Lexaria Bioscience Corp. (LEXXW) Stock Overview

Explore Lexaria Bioscience Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap29.8K
P/E Ratio-1.23
EPS (TTM)N/A
ROE-2.10%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.35
3 Months$0.00
1 Year Target$0.00

LEXXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lexaria Bioscience Corp. (LEXXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.23 and a market capitalization of 29.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-77.36%
3-Month Change
-97.45%
6-Month Change
-98.91%
Year-to-Date (YTD) Change
-86.81%
1-Year Change
-99.50%
3-Year Change
-99.76%
5-Year Change
-99.95%
All-Time (Max) Change
-99.89%

Contact Information

https://lexariabioscience.com
250 765 6424
740 McCurdy Road, Kelowna, NV, V1X 2P7

Company Facts

70 Employees
CountryUS

Frequently Asked Questions